Skip to main content
    C

    Cocrystal Pharma Inc (COCP)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $1.04
    +0.04 (+4.00%)

    Market Cap: $19.26M

    Last updated: Nov 06, 2026 at 4:10 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    76%(25/33)
    Avg Surprise
    +25.11%

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$-0.17
    Range$-0.22 - $-0.14
    3 analysts
    EPS Revisions
    1
    0
    7d
    1
    0
    30d
    EPS Estimate DriftChange to current
    90d ago$-0.17+1.0%
    60d ago$-0.17+1.0%
    30d ago$-0.14-23.8%
    7d ago$-0.14-23.8%
    Current$-0.17
    Revenue Consensus
    $0
    Range$0 - $0
    3 analysts
    Period ending Dec 31, 2026
    EPS Consensus$-0.24
    Range$-0.27 - $-0.20
    2 analysts
    Revenue Consensus
    $110M
    Range$0 - $330M
    3 analysts
    Last 12 of 39 reported quarters and 2 upcoming estimates
    PeriodReportedEst.RangeSurpriseB/MAnalystsRevisionsYoY
    Dec 26EST
    		-$-0.24$-0.27 - $-0.20--2--
    Sep 26EST
    		-$-0.17$-0.22 - $-0.14--3
    1
    0
    30d
    		-
    Jun 26
    Reported Aug 13
    		$-0.23$-0.17$-0.18 - $-0.15-35.29%Miss2
    No revisions (30d)
    		-15.0%
    Mar 26
    Reported May 15
    		$-0.17$-0.15$-0.16 - $-0.14-13.33%Miss2
    No revisions (30d)
    		+26.1%
    Dec 25
    Reported Dec 31
    		$-0.17$-0.17$-0.18 - $-0.17+2.86%Beat2
    2
    0
    30d
    		+46.9%
    Sep 25
    Reported Nov 14
    		$-0.19$-0.21$-0.22 - $-0.21+9.52%Beat2
    1
    0
    30d
    		+61.2%
    Jun 25
    Reported Aug 14
    		$-0.20$-0.30$-0.44 - $-0.20+33.33%Beat3
    No revisions (30d)
    		+62.3%
    Mar 25
    Reported May 15
    		$-0.23N/A-+55.77%Beat2
    No revisions (30d)
    		+41.0%
    Dec 24
    Reported Mar 31
    		$-0.32$-0.53$-0.62 - $-0.47+39.62%Beat3
    1
    0
    30d
    		+27.3%
    Sep 24
    Reported Nov 13
    		$-0.49$-0.57$-0.59 - $-0.55+14.04%Beat3
    No revisions (30d)
    		-19.5%
    Jun 24
    Reported Aug 14
    		$-0.53$-0.48$-0.56 - $-0.42-10.42%Miss3
    No revisions (30d)
    		-6.0%
    Mar 24
    Reported May 13
    		$-0.39$-0.56$-0.56 - $-0.52+30.36%Beat2
    No revisions (30d)
    		+39.1%
    Dec 23
    Reported Mar 28
    		$-0.44$-0.60$-0.66 - $-0.55+26.67%Beat3
    No revisions (30d)
    		+20.0%
    Sep 23
    Reported Nov 13
    		$-0.41$-0.65$-0.65 - $-0.45+36.92%Beat3
    No revisions (30d)
    		+41.4%

    Key Metrics

    Valuation
    P/E Ratio-1.37EV/EBITDAN/A
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin0.00%Operating Margin-3032.00%
    ROE-311.70%ROICN/A
    Financial Health
    Debt/Equity0.00xInterest Coverage99.40x
    Current Ratio1.24xQuick Ratio1.24x
    Trading Statistics
    Beta1.61Avg Volume35.15K
    52-Week High$2.0352-Week Low$0.76

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$1.01
    SMA 20$1.00
    SMA 50$1.09
    SMA 200$1.10
    EMA 10$1.01
    EMA 20$1.02
    EMA 50$1.05
    EMA 200$1.11

    MACD

    Line: -0.02Signal: -0.03Hist: 0.01

    ADX

    ADX: 15.7+DI: 18.7-DI: 15.6

    Aroon & PSAR

    Aroon Up4.0
    Aroon Down44.0
    PSAR$0.96

    Bollinger Bands

    Upper Band$1.10
    Lower Band$0.90
    %B Position1929%(Upper)
    Band Width0.70

    RSI (14-Day)

    Neutral
    51.2

    Momentum Oscillators

    Stoch %K56.1
    Stoch %D63.6
    Williams %R-31.6
    ROC (10d)9.5%
    Momentum0.09
    CCI (20d)25.8
    MFI (14d)63.5

    Volatility Measures

    ATR (14d)$0.06(6.2%)
    StdDev (20d)0.05
    Hist Vol51.9%(High)

    Volume Flow

    VWAP$1.02
    OBV213.9M
    AD Line-152.5M
    CMF (20d)-0.134

    Volume Metrics

    Avg Vol (20d)37.0K
    Vol Ratio0.7x
    VWMA (20d)$1.00

    Pivot Points

    R3$1.08
    R2$1.06
    R1$1.03
    Pivot Point$1.01
    S1$0.98
    S2$0.96
    S3$0.93

    Advanced Oscillators

    TSI-10.13
    Ultimate Osc48.0
    KST-102.06

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$105,000$225,000$0$0$0$0$136,000$0$0$0$144,000$0
    Cost of Revenue$0$0$-1,394,000$0$0$0$28,000$0$0$0$4.27M$0
    Gross Profit$105,000$225,000$1.39M$0$0$0$-28,000$0$0$0$-4,267,000$0
    Operating Expenses$3.29M$2.58M$2.48M$2.09M$2.11M$2.34M$3.23M$5.04M$5.45M$4.16M$4.67M$4.44M
    R&D$2.14M$1.37M$1.62M$954,000$1.12M$1.36M$2.04M$3.24M$4.31M$2.95M$4.27M$4.19M
    SG&A$1.15M$1.21M$862,000$1.14M$986,000$981,000$1.19M$1.80M$1.14M$1.21M$1.40M$1.85M
    Operating Income$-3,184,000$-2,356,000$-2,481,000$-2,089,000$-2,108,000$-2,341,000$-3,230,000$-5,042,000$-5,448,000$-4,158,000$-4,666,000$-4,443,000
    Interest Income$0$0$0$0$0$0$0$111,000$151,000$0$0$0
    Interest Expense$-10,000$-22,000$-47,000$-22,000$-28,000$-37,000$36,000$0$0$-220,000$-180,000$-320,000
    Income Before Tax$-3,164,000$-2,299,000$-2,426,000$-2,049,000$-2,055,000$-2,301,000$-3,266,000$-4,939,000$-5,343,000$-3,956,000$-4,464,000$-4,165,000
    Income Tax Expense$0$0$0$0$0$0$0$0$0$0$0$0
    Net Income$-3,164,000$-2,299,000$-2,426,000$-2,049,000$-2,055,000$-2,301,000$-3,266,000$-4,939,000$-5,343,000$-3,956,000$-4,464,000$-4,165,000
    EBITDA$-3,162,000$-2,309,000$-2,460,000$-2,058,000$-2,062,000$-2,239,000$-3,293,000$-5,020,000$-5,461,000$-4,141,000$-4,604,000$-4,432,000
    EBIT$-3,174,000$-2,321,000$-2,473,000$-2,071,000$-2,083,000$-2,338,000$-3,321,000$-5,050,000$-5,494,000$-4,176,000$-4,644,000$-4,485,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about COCP

    Government Contracts

    Gov Obligations (TTM)
    $498199
    Gov Obligations / Revenue
    N/A
    Obligations YoY
    N/A
    Active Awards
    1
    New Awards (TTM)
    1
    Avg Remaining Term
    1.8 mo

    Top agency: Department of Health and Human Services at 100.0% of trailing twelve month obligations across 1 agencies

    Recent Awards

    Award IDAgencyObligatedStart
    75N93025C00038Department of Health and Human ServicesNational Institutes of Health$498199Sep 29, 2025

    Federal contract obligations are bookings recorded by the awarding agency, not recognized revenue. They can exceed 100% of revenue and can be negative when contracts are de-obligated. Source: USAspending.gov prime awards, data through Jul 31, 2026.

    News

    Cocrystal Pharma Inc (8CC.DU) Seasonal returns chart - Yahoo Finance

    This Yahoo Finance article presents the seasonal returns chart for Cocrystal Pharma Inc (8CC.DU), showing its average monthly price return from 2021 to 2026. As of the time of the article...

    Yahoo Finance Singapore•11/4/26•Somewhat-Bearish

    Cocrystal Pharma, Inc. (COCP) Seasonal Returns Chart - Yahoo Finance

    The Yahoo Finance page for Cocrystal Pharma, Inc. (COCP) displays the stock's current price and after-hours trading activity. It also includes a "Historical Seasonality" chart showing the average monthly price return...

    Yahoo! Finance Canada•10/31/26•Neutral

    Cocrystal Pharma, Inc. (COCP) Seasonal returns chart

    This article provides a seasonality chart for Cocrystal Pharma, Inc. (COCP), displaying the average monthly price return from 2016 to 2026. It includes current stock price information and links to various financial data...

    Yahoo Finance Australia•10/30/26•Neutral

    Cocrystal Pharma, Inc. Estimates – NASDAQ:COCP

    This page on TradingView provides financial estimates and data for Cocrystal Pharma, Inc. (NASDAQ: COCP). Users can explore reported financial data and analyst estimates across various financial statements and valuation...

    TradingView•10/23/26•Neutral

    Cocrystal Pharma, Inc. (COCP) Stock Price & News

    Cocrystal Pharma, Inc. (COCP) stock is currently trading at US$0.95, a 7.20% decrease today, with a market capitalization of US$22.15M. The company, founded in 2008...

    Syfe•10/18/26•Somewhat-Bearish

    COCP Valuation and Fair Value

    P/E
    -1.4x
    PEG
    0.0x
    P/B
    13.7x
    See GNG's fair value

    COCP Profitability: Margins, ROIC and FCF

    Operating margin
    -3032.0%
    Net margin
    0.0%
    ROE
    -311.7%

    COCP Competitors

    CompanyTicker
    Quoin Pharmaceuticals Ltd DRCQNRX
    Vyne Therapeutics IncVYNE
    IGC Pharma, Inc.IGC
    Picard Medical, Inc.PMI
    Nano X Imaging LtdNNOX
    Sensei Biotherapeutics IncSNSE
    TherapeuticsMD IncTXMD
    Estrella Immunopharma Inc.ESLA

    Sector: Healthcare

    COCP Bull Case vs Bear Case

    Bull case

    • COCP beat EPS estimates in 75.0% of its last 8 reported quarters.
    • COCP grew quarterly revenue 26.9% year over year.

    COCP Earnings: Beat Rate and Next Report

    Beat rate
    6 of 8 quarters (75.0%)
    Average surprise
    13.3%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $-0.17
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    1 up, 0 down

    COCP Earnings Date

    COCP reports Nov 12, 2026. The date is estimated.

    COCP ETF Holders

    GNG tracks 3 ETFs that hold COCP. The largest weights:

    1. Vanguard Morningstar Total Stock Market ETF (VTI), <0.01% of the fund
    2. Vanguard Total Stock Market Index Fund Admiral Shares (VTSAX), <0.01% of the fund
    3. Vanguard Extended Market Index Fund ETF Shares (VXF), <0.01% of the fund
    Open the ETF Stock Exposure tool for COCP

    See insider activity

    Frequently Asked Questions About COCP

    When does COCP report earnings?

    Cocrystal Pharma Inc (COCP) is expected to report earnings on Nov 12, 2026.

    Does COCP pay dividends?

    Cocrystal Pharma Inc (COCP) does not currently pay a regular dividend.

    What is COCP's market cap?

    Cocrystal Pharma Inc (COCP) has a market capitalization of $19.26M with a current stock price of $1.04.

    Related stocks

    Sector: Healthcare

    All stocks starting with C

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In